These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 24434146)

  • 1. Suppression of protein kinase C-ζ attenuates vascular leakage via prevention of tight junction protein decrease in diabetic retinopathy.
    Song HB; Jun HO; Kim JH; Yu YS; Kim KW; Kim JH
    Biochem Biophys Res Commun; 2014 Jan; 444(1):63-8. PubMed ID: 24434146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of clusterin on blood-retinal barrier breakdown in diabetic retinopathy.
    Kim JH; Kim JH; Yu YS; Min BH; Kim KW
    Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1659-65. PubMed ID: 19875648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
    Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
    Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy.
    Kim JH; Kim JH; Jun HO; Yu YS; Kim KW
    Am J Pathol; 2010 Mar; 176(3):1517-24. PubMed ID: 20110406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability.
    Harhaj NS; Felinski EA; Wolpert EB; Sundstrom JM; Gardner TW; Antonetti DA
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5106-15. PubMed ID: 17065532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin-induced vascular hyperpermeability through tight junction disruption in diabetic retina.
    Someya H; Ito M; Nishio Y; Sato T; Harimoto K; Takeuchi M
    Exp Eye Res; 2022 Jul; 220():109094. PubMed ID: 35490836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.
    Kim JH; Kim JH; Yu YS; Cho CS; Kim KW
    J Cereb Blood Flow Metab; 2009 Mar; 29(3):621-8. PubMed ID: 19107135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation.
    Kim JH; Kim JH; Lee YM; Ahn EM; Kim KW; Yu YS
    J Cereb Blood Flow Metab; 2009 Sep; 29(9):1559-67. PubMed ID: 19536074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.
    Rota R; Chiavaroli C; Garay RP; Hannaert P
    Eur J Pharmacol; 2004 Jul; 495(2-3):217-24. PubMed ID: 15249173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression.
    Li L; Renier G
    Metabolism; 2006 Nov; 55(11):1516-23. PubMed ID: 17046555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sac-0601 prevents retinal vascular leakage in a mouse model of diabetic retinopathy.
    Maharjan S; Lee S; Agrawal V; Choi HJ; Maeng YS; Kim K; Kim NJ; Suh YG; Kwon YG
    Eur J Pharmacol; 2011 Apr; 657(1-3):35-40. PubMed ID: 21296064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of the Src inhibitor, dasatinib, on breakdown of the blood-retinal barrier.
    Kim SR; Suh W
    Arch Pharm Res; 2017 Feb; 40(2):197-203. PubMed ID: 27988882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of advanced glycation end products and activation of PKC in diabetic retinopathy].
    Kaji Y; Oshika T
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():188-93. PubMed ID: 15999705
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
    Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell factor is a potent endothelial permeability factor.
    Kim JY; Choi JS; Song SH; Im JE; Kim JM; Kim K; Kwon S; Shin HK; Joo CK; Lee BH; Suh W
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1459-67. PubMed ID: 24790137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
    Cui B; Sun JH; Xiang FF; Liu L; Li WJ
    Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cKit Inhibitor, Masitinib, Prevents Diabetes-Induced Retinal Vascular Leakage.
    Kim SR; Im JE; Jeong JH; Kim JY; Kim JT; Woo SJ; Sung JH; Park SG; Suh W
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1201-6. PubMed ID: 26978025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes.
    Canning P; Glenn JV; Hsu DK; Liu FT; Gardiner TA; Stitt AW
    Exp Diabetes Res; 2007; 2007():51837. PubMed ID: 17641742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ELOVL4-Mediated Production of Very Long-Chain Ceramides Stabilizes Tight Junctions and Prevents Diabetes-Induced Retinal Vascular Permeability.
    Kady NM; Liu X; Lydic TA; Syed MH; Navitskaya S; Wang Q; Hammer SS; O'Reilly S; Huang C; Seregin SS; Amalfitano A; Chiodo VA; Boye SL; Hauswirth WW; Antonetti DA; Busik JV
    Diabetes; 2018 Apr; 67(4):769-781. PubMed ID: 29362226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.